BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11836394)

  • 1. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.
    Zhu Q; Dudley JP
    J Virol; 2002 Mar; 76(5):2168-79. PubMed ID: 11836394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDP is a repressor of mouse mammary tumor virus expression in the mammary gland.
    Zhu Q; Gregg K; Lozano M; Liu J; Dudley JP
    J Virol; 2000 Jul; 74(14):6348-57. PubMed ID: 10864645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
    Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
    J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-induced cleavage of Cutl1/CDP generates a novel dominant-negative isoform that regulates mammary gene expression.
    Maitra U; Seo J; Lozano MM; Dudley JP
    Mol Cell Biol; 2006 Oct; 26(20):7466-78. PubMed ID: 17015474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression.
    Liu J; Bramblett D; Zhu Q; Lozano M; Kobayashi R; Ross SR; Dudley JP
    Mol Cell Biol; 1997 Sep; 17(9):5275-87. PubMed ID: 9271405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The homeodomain protein CDP regulates mammary-specific gene transcription and tumorigenesis.
    Zhu Q; Maitra U; Johnston D; Lozano M; Dudley JP
    Mol Cell Biol; 2004 Jun; 24(11):4810-23. PubMed ID: 15143175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription.
    Holmqvist PH; Belikov S; Zaret KS; Wrange O
    Exp Cell Res; 2005 Apr; 304(2):593-603. PubMed ID: 15748903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.
    Aurrekoetxea-Hernández K; Buetti E
    J Virol; 2000 Jun; 74(11):4988-98. PubMed ID: 10799572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter.
    Gouilleux F; Sola B; Couette B; Richard-Foy H
    Nucleic Acids Res; 1991 Apr; 19(7):1563-9. PubMed ID: 1851294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEF-1 transcription factors regulate activity of the mouse mammary tumor virus LTR.
    Maeda T; Maeda M; Stewart AF
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1279-85. PubMed ID: 12207913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
    Boronat S; Richard-Foy H; Piña B
    J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements.
    Mink S; Ponta H; Cato AC
    Nucleic Acids Res; 1990 Apr; 18(8):2017-24. PubMed ID: 2159634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
    Lee KI; Reddy EP; Reddy CD
    J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 5' distal palindrome within the mouse mammary tumor virus-long terminal repeat recruits a mammary gland-specific complex and is required for a synergistic response to progesterone plus prolactin.
    Morabito JE; Trott JF; Korz DM; Fairfield HE; Buck SH; Hovey RC
    J Mol Endocrinol; 2008 Aug; 41(2):75-90. PubMed ID: 18524869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells.
    Medh RD; Schmidt TJ
    J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):129-42. PubMed ID: 9393948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIII/Sa mice with a high incidence of mammary tumors express two exogenous strains and one potential endogenous strain of mouse mammary tumor virus.
    Sarkar NH; Golovkina T; Uz-Zaman T
    J Virol; 2004 Jan; 78(2):1055-62. PubMed ID: 14694140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
    Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
    Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.
    Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS
    Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor 1 and octamer transcription factor 1 binding preset the chromatin structure of the mouse mammary tumor virus promoter for hormone induction.
    Belikov S; Holmqvist PH; Astrand C; Wrange O
    J Biol Chem; 2004 Nov; 279(48):49857-67. PubMed ID: 15381691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.